Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 26020 | 265 | 28.8 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 1311 | 2 | PROSTAGLANDIN D 2//CRTH2//MOL BEHAV BIOL | 8520 |
| 26020 | 1 | ADRENOMEDULLARY OUTFLOW//SYMPATHO ADRENOMEDULLARY OUTFLOW//CENTRAL ADRENOMEDULLARY OUTFLOW | 265 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ADRENOMEDULLARY OUTFLOW | authKW | 806593 | 3% | 100% | 7 |
| 2 | SYMPATHO ADRENOMEDULLARY OUTFLOW | authKW | 263374 | 2% | 57% | 4 |
| 3 | CENTRAL ADRENOMEDULLARY OUTFLOW | authKW | 259260 | 1% | 75% | 3 |
| 4 | PROGRAM NEURAL INTEGRAT | address | 259260 | 1% | 75% | 3 |
| 5 | BRAIN PHOSPHOLIPASE A2 PLA2 | authKW | 230455 | 1% | 100% | 2 |
| 6 | CENTRAL SYMPATHO ADRENOMEDULLARY OUTFLOW | authKW | 230455 | 1% | 100% | 2 |
| 7 | BRAIN PHOSPHOLIPASE A2 | authKW | 153635 | 1% | 67% | 2 |
| 8 | SYMPATHO ADRENOMEDULLARY SYSTEM | authKW | 129627 | 1% | 38% | 3 |
| 9 | ADAPTIVE GASTRIC CYTOPROTECTION | authKW | 115228 | 0% | 100% | 1 |
| 10 | ADRENALINE PLASMA | authKW | 115228 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1493 | 44% | 0% | 117 |
| 2 | Physiology | 846 | 20% | 0% | 53 |
| 3 | Endocrinology & Metabolism | 188 | 11% | 0% | 30 |
| 4 | Neurosciences | 130 | 15% | 0% | 40 |
| 5 | Peripheral Vascular Diseases | 75 | 6% | 0% | 15 |
| 6 | Chemistry, Medicinal | 52 | 5% | 0% | 13 |
| 7 | Respiratory System | 31 | 3% | 0% | 9 |
| 8 | Medicine, Research & Experimental | 26 | 5% | 0% | 13 |
| 9 | Medicine, General & Internal | 15 | 5% | 0% | 14 |
| 10 | Sport Sciences | 15 | 2% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PROGRAM NEURAL INTEGRAT | 259260 | 1% | 75% | 3 |
| 2 | MOL PHANNACOL | 115228 | 0% | 100% | 1 |
| 3 | NEUROPHARMACOLNANKO KU | 115228 | 0% | 100% | 1 |
| 4 | PEDIATNANKO KU | 115228 | 0% | 100% | 1 |
| 5 | UROL B | 115224 | 1% | 33% | 3 |
| 6 | PROGRAM BIOSIGNALING INFECT CONTROL | 38408 | 0% | 33% | 1 |
| 7 | NANKO KU | 33901 | 8% | 1% | 20 |
| 8 | PHARMACOL CLIN PHARMACOL | 4891 | 3% | 1% | 8 |
| 9 | P AGEORGIOU GEN HOSP | 3967 | 1% | 1% | 3 |
| 10 | FIZYOLOJI ANABILIM DALI | 3290 | 0% | 3% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF PHARMACOLOGY | 4738 | 13% | 0% | 34 |
| 2 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 3282 | 2% | 1% | 5 |
| 3 | AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL | 3235 | 3% | 0% | 7 |
| 4 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3161 | 4% | 0% | 11 |
| 5 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 1330 | 1% | 0% | 3 |
| 6 | PROSTAGLANDINS | 1248 | 2% | 0% | 4 |
| 7 | MEDICAL BIOLOGY | 1242 | 1% | 1% | 2 |
| 8 | RESPIRATION PHYSIOLOGY | 1103 | 2% | 0% | 5 |
| 9 | AMERICAN JOURNAL OF PHYSIOLOGY | 1033 | 6% | 0% | 15 |
| 10 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 1015 | 2% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | YALCIN, M , (2011) CENTRAL MECHANISM UNDERLYING PRESSOR AND BRADYCARDIC EFFECT OF INTRACEREBROVENTRICULARLY INJECTED ARACHIDONIC ACID.CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 89. ISSUE 2. P. 127-133 | 16 | 57% | 0 |
| 2 | AYDIN, C , YALCIN, M , (2008) PERIPHERAL MECHANISMS INVOLVED IN THE PRESSOR AND BRADYCARDIC EFFECTS OF CENTRALLY ADMINISTERED ARACHIDONIC ACID.PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. VOL. 78. ISSUE 6. P. 361 -368 | 16 | 52% | 0 |
| 3 | YALCIN, M , SAVCI, V , (2007) CARDIOVASCULAR EFFECTS OF CENTRALLY INJECTED MELITTIN IN HEMORRHAGED HYPOTENSIVE RATS: THE INVESTIGATION OF PERIPHERAL MECHANISMS.NEUROPEPTIDES. VOL. 41. ISSUE 6. P. 465-475 | 15 | 56% | 3 |
| 4 | TOPUZ, BB , ALTINBAS, B , ILHAN, T , YILMAZ, MS , ERDOST, H , SAHA, S , SAVCI, V , YALCIN, M , (2014) CENTRALLY ADMINISTERED CDP-CHOLINE INDUCED CARDIOVASCULAR RESPONSES ARE MEDIATED BY ACTIVATION OF THE CENTRAL PHOSPHOLIPASE-PROSTAGLANDIN SIGNALING CASCADE.BRAIN RESEARCH. VOL. 1563. ISSUE . P. 61 -71 | 16 | 36% | 0 |
| 5 | YALCIN, M , AYDIN, C , (2009) CARDIOVASCULAR EFFECTS OF CENTRALLY ADMINISTERED ARACHIDONIC ACID IN HAEMORRHAGE-INDUCED HYPOTENSIVE RATS: INVESTIGATION OF A PERIPHERAL MECHANISM.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 36. ISSUE 4. P. 447-453 | 15 | 42% | 2 |
| 6 | YALCIN, M , SAVCI, V , (2004) RESTORATION OF BLOOD PRESSURE BY CENTRALLY INJECTED U-46619, A THROMBOXANE A(2) ANALOG, IN HEMORRHAGED HYPOTENSIVE RATS: INVESTIGATION OF DIFFERENT BRAIN AREAS.PHARMACOLOGY. VOL. 70. ISSUE 4. P. 177-187 | 14 | 48% | 21 |
| 7 | ERKAN, LG , GUVENC, G , ALTINBAS, B , NIAZ, N , YALCIN, M , (2016) THE EFFECTS OF CENTRALLY INJECTED ARACHIDONIC ACID ON RESPIRATORY SYSTEM: INVOLVEMENT OF CYCLOOXYGENASE TO THROMBOXANE SIGNALING PATHWAY.RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY. VOL. 225. ISSUE . P. 1 -7 | 11 | 46% | 0 |
| 8 | MURAKAMI, Y , OKADA, S , NISHIHARA, M , YOKOTANI, K , (2002) ROLES OF BRAIN PROSTAGLANDIN E-2 AND THROMBOXANE A(2) IN THE ACTIVATION OF THE CENTRAL SYMPATHO-ADRENOMEDULLARY OUTFLOW IN RATS.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 452. ISSUE 3. P. 289-294 | 13 | 46% | 30 |
| 9 | YALCIN, M , AYDIN, C , (2011) THE ROLE OF THE CENTRAL ARACHIDONIC ACID-THROMBOXANE A(2) CASCADE IN CARDIOVASCULAR REGULATION DURING HEMORRHAGIC SHOCK IN RATS.PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. VOL. 85. ISSUE 2. P. 61-66 | 12 | 40% | 1 |
| 10 | ALTINBAS, B , TOPUZ, BB , ILHAN, T , YILMAZ, MS , ERDOST, H , YALCIN, M , (2014) ACTIVATION OF THE CENTRAL HISTAMINERGIC SYSTEM MEDIATES ARACHIDONIC-ACID-INDUCED CARDIOVASCULAR EFFECTS.CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 92. ISSUE 8. P. 645 -654 | 14 | 32% | 0 |
Classes with closest relation at Level 1 |